≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Pneumocystosis

EFO Endpoint Browser PheWeb

AB1_PNEUMOCYSTOSIS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — B59
  • Hospital discharge: ICD-9 — 1363
  • Hospital discharge: ICD-8 — 13601
  • Cause of death: ICD-10 — B59
  • Cause of death: ICD-9 — 1363
  • Cause of death: ICD-8 — 13601

2 out of 7 registries used, show all original rules.

525

4. Check minimum number of events

None

525

5. Include endpoints

None

525

6. Filter based on genotype QC (FinnGen only)

525

Control definitions (FinnGen only)

Control exclude
AB1_PROTOZOAL

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2264 930 1311
Only index persons 1857 788 1069
Unadjusted period prevalence (%)
Whole population 0.03 0.03 0.04
Only index persons 0.04 0.03 0.04
Median age at first event (years)
Whole population 65.64 66.13 65.45
Only index persons 67.08 67.10 67.08

-FinnGen-

Key figures

All Female Male
Number of individuals 525 235 290
Unadjusted period prevalence (%) 0.11 0.08 0.13
Median age at first event (years) 66.93 66.73 67.09

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
446
Matched controls
4458
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
+∞
323.0
367
*
TGC00
NOMESCO Finland
Bronchial lavation
67.8
182.0
207
56
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
27.6
144.5
209
138
UGC12
NOMESCO Finland
Flexible bronchoscopy
24.8
143.6
217
164
J18.9
ICD-10 Finland
Pneumonia, unspecified
12.2
122.9
305
673
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
23.5
115.7
174
118
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
22.0
109.4
168
119
B59
ICD-10 Finland
Pneumocystosis
+∞
101.0
93
*
R50.9
ICD-10 Finland
Fever, unspecified
10.5
93.5
217
370
GD1AA
NOMESCO Finland
Thorax X-ray examination
9.5
90.0
372
1545
H02AB06
ATC
prednisolone; systemic
8.1
81.8
360
1517
A49.9
ICD-10 Finland
Bacterial infection, unspecified
9.5
77.5
183
303
XW000
NOMESCO Finland
Bone marrow biopsy
14.1
65.5
118
111
ZX108
NOMESCO Finland
Inhalation
63.1
64.3
74
14
JN4BD
NOMESCO Finland
Extensive body CT
7.8
63.1
168
320
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
14.1
62.9
113
105
L03AA02
ATC
filgrastim; parenteral
19.4
61.6
96
62
ZX120
NOMESCO Finland
Intravenous
8.6
60.2
146
238
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
8.1
58.2
147
254
A03FA01
ATC
metoclopramide; systemic, rectal
5.5
53.8
203
588
WW500
NOMESCO Finland
Blood transfusion
12.4
53.2
101
103
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
15.4
52.8
90
72
H02AB02
ATC
dexamethasone; systemic
7.4
51.7
138
254
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
15.6
50.9
86
67
A04AA01
ATC
ondansetron; systemic, rectal
9.2
50.2
113
158
JN4AD
NOMESCO Finland
Body CT examination
7.6
50.2
131
232
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.4
47.6
255
1029
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
8.1
47.3
116
185
M04AA01
ATC
allopurinol; systemic
5.5
44.1
153
385
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
19.8
42.6
65
38
L03AA13
ATC
pegfilgrastim; parenteral
11.4
42.1
82
86
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.9
41.9
166
480
L04AA06
ATC
mycophenolic acid; systemic
25.0
41.8
59
27
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
18.4
41.5
65
41
J05AB11
ATC
valaciclovir; oral
5.7
39.7
129
296
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
9.9
39.3
83
101
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
7.8
39.3
97
153
J01MA14
ATC
moxifloxacin; systemic
6.6
38.2
107
202
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
21.9
38.1
56
29
127
Kela drug reimbursment
Transplant complication
24.4
38.1
54
25
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.8
37.9
93
145
D70.82
ICD-10 Finland
Drug-induced neutropenia
21.2
37.7
56
30
J01FF01
ATC
clindamycin; systemic
3.9
37.2
206
800
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
13.2
37.2
67
59
Z51.5
ICD-10 Finland
Palliative care
7.4
36.5
93
153
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
375.3
35.5
35
*
J01MA12
ATC
levofloxacin; systemic
4.2
34.8
165
552
A02BC02
ATC
pantoprazole; systemic
4.1
34.6
368
2375
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.7
33.3
132
369
A04AA02
ATC
granisetron; systemic, transdermal
7.0
32.1
85
146
GD1AD
NOMESCO Finland
Thorax CT examination
7.6
32.1
79
122
N02AA05
ATC
oxycodone; systemic
4.4
31.7
133
391
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
5.8
30.4
94
197
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.9
30.4
80
136
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.3
30.3
219
1005
C03CA01
ATC
furosemide; systemic
3.4
29.9
201
872
L04AX01
ATC
azathioprine; systemic
8.4
29.8
68
93
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
15.1
29.3
49
36
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
11.4
28.4
54
53
TPH04
NOMESCO Finland
Cathetrisation of vein
3.6
28.2
159
596
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.4
27.9
53
52
L04AD01
ATC
ciclosporin; systemic
14.5
27.1
46
35
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
16.1
27.1
44
30
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.6
26.9
105
282
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
24.4
24.3
34
15
L03AA14
ATC
lipegfilgrastim; parenteral
15.7
23.9
39
27
1CX01
NOMESCO Finland
NA
49.6
23.6
28
6
Z2446
NOMESCO Finland
Social worker
6.0
23.6
68
129
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
12.1
23.5
43
39
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
23.6
23.4
33
15
ZX112
NOMESCO Finland
Subcutaneous
11.8
23.2
43
40
WW200
NOMESCO Finland
Immunization
9.3
22.8
48
57
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.4
22.3
124
448
1XC02
NOMESCO Finland
NA
40.9
22.0
27
7
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
28.1
21.6
29
11
TK800
NOMESCO Finland
Hemodialysis
11.2
21.1
40
39
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
18.0
20.8
32
19
D70.89
ICD-10 Finland
Neutropenic splenomegaly
18.0
20.8
32
19
H02AB07
ATC
prednisone; oral
3.5
20.5
109
377
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.3
20.4
82
223
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
50.5
20.4
24
5
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
18.4
20.3
31
18
WX892
NOMESCO Finland
Monitored bed care
4.8
20.3
72
173
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
20.0
20.2
30
16
R4110
NOMESCO Finland
Physiotherapy
2.8
20.1
174
837
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
6.0
19.9
57
107
Z3231
NOMESCO Finland
Registered nurse
2.7
19.7
174
846
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
12.6
19.6
35
30
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.6
19.4
71
176
H02AB04
ATC
methylprednisolone; systemic
3.3
19.3
109
393
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
18.1
19.0
29
17
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.5
18.5
258
1598
A11CC03
ATC
alfacalcidol; systemic
10.5
18.5
36
37
Z94.0
ICD-10 Finland
Kidney transplant status
17.5
18.1
28
17
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
17.9
212
1197
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
15.4
17.9
29
20
J05AB01
ATC
aciclovir; systemic
2.8
17.3
131
572
Z49.1
ICD-10 Finland
Extracorporeal dialysis
14.0
17.2
29
22
L04AA01
ATC
[U] ciclosporin; systemic
11.0
17.0
32
31
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
10.4
17.0
33
34
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.4
17.0
220
1290
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
66.0
16.9
19
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
6.7
16.7
43
70
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
8.6
16.6
36
45
J02AC03
ATC
voriconazole; systemic
176.3
16.6
17
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
24.2
16.6
23
10
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
8.5
16.1
35
44
JN6AD
NOMESCO Finland
CT of torso and neck
12.9
16.1
28
23
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.7
16.1
76
237
R06.0
ICD-10 Finland
Dyspnoea
2.5
16.0
153
760
B01AB05
ATC
enoxaparin; parenteral
2.4
16.0
178
959
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.1
15.6
50
107
Z2221
NOMESCO Finland
Medical doctor
2.5
15.5
155
786
WF049
NOMESCO Finland
Radiotherapy of metastasis
6.0
15.4
43
78
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
15.4
174
938
XF400
NOMESCO Finland
ECG with 12 standard connections
2.8
15.2
112
476
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
46.7
15.2
18
*
A41.9
ICD-10 Finland
Sepsis, unspecified
5.7
15.1
44
84
Z3226
NOMESCO Finland
Physiotherapist
2.7
15.1
117
514
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.8
14.9
51
117
B03XA01
ATC
erythropoietin; parenteral
17.2
14.9
23
14
B01AB10
ATC
tinzaparin; parenteral
3.9
14.9
65
189
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.4
14.8
77
258
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
26.1
14.8
20
8
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
8.0
14.7
33
44
WX726
NOMESCO Finland
High-flow oxygen therapy
+∞
14.7
14
*
6BA02
NOMESCO Finland
NA
82.9
14.7
16
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
28.3
14.4
19
7
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
20.0
14.4
21
11
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.6
14.2
68
213
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
5.0
14.0
45
97
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
55.2
13.9
16
*
A12AA04
ATC
calcium carbonate; oral
9.8
13.7
27
29
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
77.6
13.7
15
*
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
144.2
13.5
14
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.6
13.5
115
528
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.8
13.4
58
167
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
11.0
13.4
25
24
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
15.7
13.2
21
14
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.3
13.2
72
247
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.7
13.2
99
423
A07EC01
ATC
sulfasalazine; oral, rectal
3.5
13.2
64
203
B03XA02
ATC
darbepoetin alfa; parenteral
9.2
13.2
27
31
M05BX04
ATC
denosumab; parenteral
4.5
13.1
47
114
L01AA01
ATC
cyclophosphamide; systemic
29.4
13.0
17
6
A05AA02
ATC
ursodeoxycholic acid; oral
12.1
13.0
23
20
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
4.3
12.9
49
125
WX002
NOMESCO Finland
Sedation and analgesia
2.5
12.9
121
586
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.1
12.8
75
271
ZXE00
NOMESCO Finland
One hour or less
2.1
12.8
206
1283
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.4
12.7
133
679
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
11.0
12.4
23
22
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
14.9
12.4
20
14
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.9
12.3
78
299
A04AA55
ATC
palonosetron, combinations; systemic
6.9
12.3
30
46
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
6.1
12.2
33
58
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.1
12.2
33
58
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.6
12.2
103
469
D64.9
ICD-10 Finland
Anaemia, unspecified
3.0
12.2
73
270
C90.0
ICD-10 Finland
Multiple myeloma
9.7
12.1
24
26
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
10.5
12.1
23
23
C83.1
ICD-10 Finland
Mantle cell lymphoma
27.6
12.1
16
6
B02.9
ICD-10 Finland
Zoster without complication
4.3
12.1
45
113
WF004
NOMESCO Finland
Palliative radiotherapy
6.8
12.1
30
47
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.1
11.9
184
1115
HA1AA
NOMESCO Finland
X-ray mammography
4.0
11.7
48
132
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
11.7
75
290
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.5
11.7
56
176
390
Kela drug reimbursment
Ibrutinib
66.8
11.7
13
*
WX720
NOMESCO Finland
Own respiration
5.0
11.6
37
79
KA1AE
NOMESCO Finland
Kidney ultrasound examination
7.8
11.6
26
35
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.8
11.5
49
139
M05BA04
ATC
alendronic acid; oral
3.4
11.4
57
185
L01AA02
ATC
chlorambucil; oral
36.0
11.3
14
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.3
11.0
41
103
H02AB09
ATC
hydrocortisone; systemic
7.2
11.0
26
38
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
44.5
11.0
13
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
44.5
11.0
13
*
137
Kela drug reimbursment
Uraemia requiring dialysis
16.0
10.9
17
11
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
10.0
10.9
21
22
WW409
NOMESCO Finland
Other aferesis
28.8
10.8
14
5
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.5
10.7
37
87
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
9.5
10.6
21
23
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
9.5
10.6
21
23
N02AX02
ATC
tramadol; systemic, rectal
2.0
10.6
211
1395
J01DB01
ATC
cefalexin; oral
2.2
10.6
368
3026
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.0
10.5
42
113
XX3DW
NOMESCO Finland
Time consuming IT work
2.8
10.5
71
283
L01XE27
ATC
[U] ibrutinib; oral
112.6
10.5
11
*
L01BB05
ATC
fludarabine; systemic
112.6
10.5
11
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.4
10.4
37
89
RD210
NOMESCO Finland
NA
9.1
10.4
21
24
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.3
10.4
105
520
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
24.0
10.3
14
6
P01BA02
ATC
hydroxychloroquine; oral
3.1
10.3
58
205
TDM10
NOMESCO Finland
Puncture of maxillary antrum
5.2
10.2
31
63
C82.1
ICD-10 Finland
Follicular lymphoma grade II
13.5
10.2
17
13
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
10.2
147
854
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.6
10.2
46
138
WZC30
NOMESCO Finland
Teaching
2.5
10.2
84
376
A07AA02
ATC
nystatin; oral
3.4
10.1
50
161
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
7.5
10.1
23
32
A04AD12
ATC
aprepitant; systemic
7.3
9.9
23
33
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.4
9.8
35
85
1512
Kela drug reimbursment
Ibrutinib
56.2
9.7
11
*
M31.3
ICD-10 Finland
Wegener granulomatosis
56.2
9.7
11
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
56.2
9.7
11
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.2
9.7
36
91
ZXD05
NOMESCO Finland
Urgent procedure
2.0
9.6
157
955
3AC01
NOMESCO Finland
NA
15.5
9.6
15
10
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.0
9.6
58
214
TQW99
NOMESCO Finland
Other minor procedure on skin
4.2
9.5
35
88
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.5
9.4
44
136
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
+∞
9.4
9
*
B05DA
ATC
Isotonic solutions
22.3
9.4
13
6
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
4.3
9.4
34
84
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
9.0
9.4
19
22
JN4CD
NOMESCO Finland
Very extensive body CT
4.0
9.4
37
99
N18.0
ICD-10 Finland
End-stage renal disease
9.8
9.3
18
19
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
9.3
84
394
ZXA00
NOMESCO Finland
Right side
2.0
9.3
142
838
N03AX16
ATC
pregabalin; oral
2.1
9.3
126
710
R03AC02
ATC
salbutamol; inhalant
1.9
9.2
236
1678
E0000UV
ATC
NA
1.9
9.2
176
1132
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
10.3
9.1
17
17
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
37.5
9.1
11
*
V03AE02
ATC
sevelamer; oral
37.5
9.1
11
*
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
4.8
9.0
29
64
R2110
NOMESCO Finland
Giving the first information
3.7
8.9
39
114
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
9.8
8.8
17
18
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
8.8
55
208
XX1XW
NOMESCO Finland
Extensive written report from radiologist
7.4
8.8
20
28
WX725
NOMESCO Finland
Noninvasive ventilation
3.9
8.8
35
95
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
51.0
8.7
10
*
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
51.0
8.7
10
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
8.7
187
1245
J01CA04
ATC
amoxicillin; systemic
2.0
8.7
352
2912
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
4.6
8.6
29
67
J02AC01
ATC
fluconazole; systemic
1.9
8.6
162
1031
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
28.1
8.5
11
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.0
8.5
26
54
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
20.5
8.5
12
6
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
20.5
8.5
12
6
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
13.1
8.4
14
11
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
5.7
8.4
23
42
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
5.0
8.4
26
55
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
8.8
8.4
17
20
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
11.0
8.3
15
14
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
11.0
8.3
15
14
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
4.7
8.3
27
60
R11
ICD-10 Finland
Nausea and vomiting
3.0
8.3
47
167
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.9
8.3
49
180
DHA10
NOMESCO Finland
Biopsy of cavity of nose
14.8
8.2
13
9
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.2
8.2
43
145
WX722
NOMESCO Finland
PEEP
3.6
8.2
36
106
V03AE03
ATC
lanthanum carbonate; oral
34.0
8.1
10
*
WX610
NOMESCO Finland
Patient controlled analgesia
22.5
8.0
11
5
B05DB
ATC
Hypertonic solutions
22.5
8.0
11
5
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
22.5
8.0
11
5
PJA10
NOMESCO Finland
Exploration of lymph nodes
7.5
8.0
18
25
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.0
8.0
46
165
TAB00
NOMESCO Finland
Lumbar puncture
3.6
8.0
35
103
R81
ICPC
Pneumonia
4.5
8.0
27
63
N02BE01
ATC
paracetamol; systemic, rectal
2.1
7.9
386
3349
RS220
NOMESCO Finland
NA
8.7
7.9
16
19
K65.0
ICD-10 Finland
Acute peritonitis
11.1
7.8
14
13
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.2
7.8
23
46
WX882
NOMESCO Finland
High dependency care
4.3
7.8
28
69
XG410
NOMESCO Finland
Flow-volume spirometry
3.8
7.7
32
90
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
45.8
7.7
9
*
XF600
NOMESCO Finland
Bloodpressure measurement
3.2
7.7
40
135
EBA10
NOMESCO Finland
Surgical removal of tooth
2.6
7.7
56
234
J96.0
ICD-10 Finland
Acute respiratory failure
8.3
7.7
16
20
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
5.3
7.7
22
43
Z49.2
ICD-10 Finland
Other dialysis
18.7
7.6
11
6
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
12.1
7.6
13
11
153
Kela drug reimbursment
Lenalidomid
12.1
7.6
13
11
TK820
NOMESCO Finland
Peritoneal dialysis
25.5
7.6
10
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
9.1
7.6
15
17
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
7.6
207
1473
J12.8
ICD-10 Finland
Other viral pneumonia
10.3
7.6
14
14
AA1AD
NOMESCO Finland
CT of head and brain
1.9
7.6
128
775
SPAT1255
SPAT
Intravenous administration of medicine
2.8
7.5
47
177
SPAT1325
SPAT
Vaccination
1.8
7.4
171
1151
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
81.4
7.4
8
*
N19
ICD-10 Finland
Unspecified kidney failure
4.3
7.4
26
63
C07AB07
ATC
bisoprolol; oral
1.7
7.4
224
1638
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
7.4
70
334
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
11.1
7.3
13
12
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.1
7.3
39
134
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
7.3
7
*
1AA09
NOMESCO Finland
NA
+∞
7.3
7
*
ZX131
NOMESCO Finland
Intrathecal
+∞
7.3
7
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
7.3
7
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.9
7.3
43
158
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.8
7.3
46
176
D69.5
ICD-10 Finland
Secondary thrombocytopenia
16.1
7.3
11
7
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
4.6
7.3
24
55
J01MA02
ATC
ciprofloxacin; systemic
1.8
7.2
184
1275
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
30.5
7.2
9
*
A46
ICD-10 Finland
Erysipelas
2.1
7.1
82
425
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
12.3
7.1
12
10
Z3229
NOMESCO Finland
Other healthcare associate professional
2.6
7.1
51
209
N18.8
ICD-10 Finland
Other chronic renal failure
4.6
7.1
23
52
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
5.3
7.0
20
39
L04AA13
ATC
leflunomide; oral
4.8
7.0
22
48
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
7.0
131
822
A07AA09
ATC
vancomycin; oral
7.7
7.0
15
20
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
6.9
69
338
A02BC05
ATC
esomeprazole; systemic
1.7
6.9
179
1241
R4190
NOMESCO Finland
Nutritional therapy
4.0
6.9
26
68
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
6.9
6.9
16
24
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.4
6.9
32
100
WX110
NOMESCO Finland
Local anesthesy
1.7
6.9
302
2446
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
6.3
6.8
17
28
L04AX04
ATC
lenalidomide; oral
11.2
6.8
12
11
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
40.7
6.8
8
*
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
40.7
6.8
8
*
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
17.0
6.8
10
6
C08CA01
ATC
amlodipine; oral
1.7
6.8
174
1202
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
22.9
6.7
9
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
22.9
6.7
9
*
Z94.2
ICD-10 Finland
Lung transplant status
22.9
6.7
9
*
ZX121
NOMESCO Finland
Central venous catheter
22.9
6.7
9
*
329
Kela drug reimbursment
Lenalidomide
22.9
6.7
9
*
RS221
NOMESCO Finland
NA
6.6
6.7
16
25
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.3
6.6
31
98
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
6.6
105
621
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
7.0
6.6
15
22
J47
ICD-10 Finland
Bronchiectasis
6.3
6.5
16
26
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
70.8
6.4
7
*
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
70.8
6.4
7
*
L01XX52
ATC
venetoclax; oral
70.8
6.4
7
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
70.8
6.4
7
*
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
14.6
6.4
10
7
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
14.6
6.4
10
7
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
8.3
6.4
13
16
L01BC06
ATC
capecitabine; oral
3.5
6.4
28
84
A03
ICPC
Fever
2.1
6.4
71
363
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.1
6.3
33
113
B02
ICD-10 Finland
Zoster [herpes zoster]
3.8
6.3
25
69
1XX08
NOMESCO Finland
NA
+∞
6.3
6
*
B73
ICPC
Leukaemia
+∞
6.3
6
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
6.3
96
559
WW400
NOMESCO Finland
Plasmaferesis
27.1
6.2
8
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
27.1
6.2
8
*
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
27.1
6.2
8
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
27.1
6.2
8
*
R06AE07
ATC
cetirizine; oral
1.7
6.2
177
1255
N05CF01
ATC
zopiclone; oral
1.7
6.2
143
950
R28
ICPC
Limited function/disability (R)
7.8
6.2
13
17
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
5.0
6.1
18
37
5BA08
NOMESCO Finland
NA
12.7
6.1
10
8
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
6.8
6.1
14
21
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
4.1
6.1
22
56
R05
ICD-10 Finland
Cough
1.9
6.1
93
541
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.3
6.1
17
33
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
5.3
6.1
17
33
TGD00
NOMESCO Finland
Needle biopsy of lung
10.2
6.1
11
11
M01CB01
ATC
sodium aurothiomalate; parenteral
6.2
6.0
15
25
A41.8
ICD-10 Finland
Other specified sepsis
6.2
6.0
15
25

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
211
81
42.88
322.40
2.9
1.9
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
240
93
46.70
307.65
7.4
7.3
iu/ml
379.4
393.5
0.02
46
17
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
248
113
40.70
307.65
3.0
1.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
336
46
201.12
307.65
2.0
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
240
91
47.74
307.65
2.2
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
214
75
47.48
307.65
2.1
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
248
115
39.98
307.65
2.9
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
250
175
26.36
298.39
3.4
3.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
183
64
43.36
286.31
2.5
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
182
70
39.27
275.85
2.3
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
184
79
35.32
268.23
2.3
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
133
24
73.88
242.08
1.3
1.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
169
78
31.48
238.65
3.9
3.9
u/ml
1124.4
3153.0
—
12
9
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
146
46
43.58
233.70
2.6
1.8
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
132
32
54.77
225.75
2.6
1.8
%
27.3
32.4
—
13
5
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
184
122
22.68
221.36
1.9
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
132
42
41.65
209.95
3.1
1.9
e9/l
1.0
1.0
0.22
95
20
(44790048)
140
61
30.93
200.61
2.3
1.5
—
—
—
0
0
(44790049)
140
61
30.93
200.61
2.3
1.5
—
—
—
0
0
(44806118)
140
61
30.93
200.61
2.3
1.5
—
—
—
0
0
(44790047)
140
61
30.93
200.61
2.3
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
311
543
12.60
197.36
3.6
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
356
764
12.37
188.86
4.2
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
300
543
11.56
182.83
3.3
1.9
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
95
13
89.00
179.34
1.3
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
110
32
43.22
178.54
3.5
2.1
e6/l
435.7
682.7
0.71
37
15
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
107
29
46.09
176.89
2.4
1.8
%
13.3
12.9
0.04
36
16
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
103
29
43.94
168.38
2.6
1.9
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
103
31
41.09
165.29
4.0
2.7
%
31.8
44.0
1.23
29
11
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
112
51
27.65
156.58
3.0
2.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
277
536
9.82
155.90
12.0
4.0
u/l
268.8
258.7
0.25
271
504
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
114
55
26.20
155.77
3.0
2.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
418
1318
11.65
147.44
12.7
4.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
277
573
9.12
145.38
2.4
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
72
11
75.70
132.86
2.0
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
86
29
35.27
132.78
2.7
1.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
80
22
42.72
130.81
2.8
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
295
719
8.08
130.14
2.6
2.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
79
23
40.25
127.15
2.8
1.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
158
207
10.49
120.23
3.1
1.9
ug/l
1.0
3.0
0.79
148
185
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
81
31
30.71
119.76
2.9
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
103
72
17.55
117.56
3.2
2.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
260
629
7.21
112.99
15.3
5.8
mmol/l
1.1
1.0
0.40
254
584
(3028026) IgM [Mass/volume] in Serum or Plasma
176
294
8.50
108.73
3.1
1.7
g/l
1.0
1.4
1.85
154
272
(3028433) Virus identified in Specimen by Culture
66
20
37.60
104.63
1.3
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
187
347
7.82
104.62
2.8
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
395
1489
7.67
104.58
21.6
5.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
197
389
7.51
103.80
9.2
4.3
%
1.1
0.9
0.92
137
123
(3019069) Monocytes/100 leukocytes in Blood
465
2062
11.98
103.33
23.0
6.2
%
8.8
8.8
0.06
457
1939
(3012095) Magnesium [Moles/volume] in Serum or Plasma
277
770
6.50
102.21
8.4
3.6
mmol/l
0.8
0.8
0.72
267
723
(46235355) HIV 1 and 2 tests - Meaningful Use set
238
575
6.74
102.09
2.0
1.8
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
74
34
25.17
101.97
3.7
1.9
e6/l
517.5
451.5
0.30
69
27
(3002030) Lymphocytes/100 leukocytes in Blood
466
2102
11.83
100.64
22.5
6.0
%
24.7
27.4
3.30
459
1962
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
78
42
21.64
100.58
1.5
1.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
453
1990
10.31
100.39
21.8
5.8
%
0.6
0.7
1.71
447
1865
(3006504) Eosinophils/100 leukocytes in Blood
460
2055
11.00
100.07
22.2
5.9
%
2.1
3.0
15.83
452
1924
(3021879) Hepatitis B virus core Ab [Presence] in Serum
162
270
8.23
99.64
1.8
1.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
460
2068
10.89
98.94
20.5
5.8
%
60.3
57.1
4.14
454
1945
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
80
48
19.48
98.10
3.3
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
80
48
19.48
98.10
3.2
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
80
48
19.48
98.10
3.3
1.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
473
2199
12.62
97.89
20.2
5.7
e9/l
0.0
0.0
4.05
451
1909
(3023419) Bacteria identified in Sputum by Culture
95
79
14.46
97.81
2.7
2.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
471
2188
12.21
97.27
20.3
5.7
e9/l
0.6
0.6
1.89
448
1888
(3019198) Lymphocytes [#/volume] in Blood
473
2235
12.27
94.99
20.6
5.8
e9/l
2.1
1.9
0.24
457
1968
(3013115) Eosinophils [#/volume] in Blood
475
2262
12.55
94.36
22.8
5.9
e9/l
0.1
0.2
15.42
459
1987
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
99
94
12.75
93.72
1.5
1.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
137
203
8.78
92.96
3.1
1.5
u/ml
10.0
7.6
—
11
6
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
94
84
13.41
92.46
1.5
1.4
u/ml
88.8
99.4
0.32
14
14
(3017143) Hepatitis C virus Ab [Presence] in Serum
190
440
6.20
83.24
2.3
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
90
91
11.73
81.34
2.3
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
212
553
5.75
81.16
5.9
2.6
%
2.0
1.8
1.36
201
507
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
90
92
11.60
80.72
1.3
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
105
134
9.54
79.95
1.8
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
81
72
13.12
79.60
1.3
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
345
1390
5.32
76.89
14.4
4.0
ph
7.4
7.4
0.56
92
251
(3013650) Neutrophils [#/volume] in Blood by Automated count
482
2578
11.62
76.87
39.9
9.3
e9/l
4.3
4.1
0.92
469
2270
(3045142) Bone marrow Pathology biopsy report
74
60
14.19
76.85
1.6
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
191
484
5.63
74.87
2.0
1.5
—
—
—
0
0
(4035726)
175
417
5.79
73.38
1.7
1.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
414
1986
6.13
72.82
14.2
5.1
g/l
32.7
35.2
12.43
399
1866
(3021440) Promyelocytes/100 leukocytes in Blood
162
363
6.01
72.62
9.8
4.5
%
0.2
0.1
0.54
122
108
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
69
55
14.29
72.27
3.5
3.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
82
87
10.98
71.41
1.3
1.3
u/ml
269.6
288.2
0.14
60
48
(3023520) Reticulocytes [#/volume] in Blood
173
418
5.68
71.22
5.7
2.7
e9/l
73.1
71.6
0.15
126
330
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
457
2421
7.85
70.46
21.8
6.5
umol/l
10.1
11.6
2.78
451
2297
(3048929) Epstein Barr virus Ab [Presence] in Serum
97
131
8.86
70.24
1.4
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
123
218
7.06
69.91
2.6
2.1
g/l
1.6
1.5
0.07
101
191
(3002179) Metamyelocytes/100 leukocytes in Blood
156
353
5.86
68.88
9.6
4.2
%
0.6
0.4
1.14
97
86
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
41
10
44.39
68.20
1.1
1.5
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
201
580
5.00
66.58
12.0
8.3
kpa
10.5
12.0
4.44
193
559
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
201
580
5.00
66.58
12.0
8.3
kpa
4.8
5.1
7.09
193
557
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
101
152
7.99
66.57
3.8
2.6
u/ml
0.4
0.4
0.02
68
83
(3026782) Osmolality of Urine
260
920
4.62
66.19
4.7
2.9
mosm/kgh2o
545.0
561.4
0.61
249
778
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
439
2311
6.49
66.15
24.6
7.3
mmol/l
1.2
1.2
2.36
368
1956
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
420
2143
5.80
65.44
20.6
6.2
mmol/l
1.2
1.2
2.74
410
1933
(3003396) Base excess in Arterial blood by calculation
198
577
4.90
64.53
12.0
8.4
mmol/l
0.9
1.3
0.56
158
458
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
56
41
15.17
61.36
1.1
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
261
969
4.37
61.32
4.7
2.6
e6/l
4.1
5.1
0.47
251
852
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
361
1703
4.58
60.51
6.6
3.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
86
120
8.37
60.29
1.9
1.7
—
—
—
0
0
(3012544) pH of Venous blood
172
470
4.96
60.25
10.1
4.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
75
89
9.66
59.87
6.2
2.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
56
43
14.46
59.70
2.3
2.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
74
87
9.74
59.48
1.9
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
74
87
9.74
59.48
1.9
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
168
457
4.94
59.06
10.2
3.9
mmol/l
1.9
2.0
0.11
138
362
(3025159) Blasts/100 leukocytes in Blood
143
343
5.36
58.37
9.6
4.5
%
0.0
0.1
0.53
99
93
(3001964) Herpes simplex virus Ag [Presence] in Specimen
39
14
30.01
58.07
1.5
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
64
9
80.60
57.57
2.1
1.8
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
39
15
28.01
56.72
2.6
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
202
655
4.39
56.29
4.4
2.4
g/l
2.1
2.3
4.42
195
607
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
197
630
4.40
55.88
4.5
2.4
%
21.8
22.4
0.26
179
530
(3024139) IgG subclass 3 [Mass/volume] in Serum
49
34
15.79
55.17
1.6
1.4
g/l
0.4
0.4
0.03
29
25
(3028192) IgG subclass 2 [Mass/volume] in Serum
49
34
15.79
55.17
1.6
1.4
g/l
1.9
2.6
1.11
33
26
(3027135) IgG subclass 1 [Mass/volume] in Serum
49
34
15.79
55.17
1.6
1.4
g/l
6.4
7.0
0.19
30
26
(3019060) Gas panel - Arterial blood
140
346
5.15
54.93
7.7
6.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
38
15
27.23
54.74
3.9
1.9
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
46
29
17.29
54.40
1.7
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
209
711
4.22
54.26
4.4
2.4
umol/l
11.3
12.8
2.39
203
656
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
47
32
16.03
53.42
6.3
3.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
65
75
9.75
52.84
8.8
3.5
%
1.4
1.4
0.04
59
63
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
116
253
5.60
52.38
11.3
10.0
mmol/l
24.2
24.6
0.68
111
237
(3030467) Casts [#/volume] in Urine by Automated count
296
1307
3.90
52.18
6.5
3.3
e6/l
0.2
0.5
2.88
264
989
(3002582) Erythrocytes [#/volume] in Urine
311
1423
3.91
51.88
6.5
3.4
e6/l
27.7
105.2
1.02
281
1108
(4062490)
48
36
14.57
51.72
1.6
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
287
1256
3.83
50.97
6.4
3.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
267
1116
3.83
50.78
27.8
6.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
371
1938
4.12
50.17
13.5
9.4
inr
1.2
1.3
1.62
108
542
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
53
50
11.68
49.60
2.0
1.1
u/ml
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
60
68
9.83
49.36
1.5
1.8
g/l
0.4
0.8
1.43
40
55
(3000991) Gas panel - Venous blood
149
420
4.56
49.24
14.0
8.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
64
80
8.97
48.82
7.5
3.5
%
58.8
57.9
0.13
64
80
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
87
156
6.49
48.09
2.3
1.6
titre
600.0
163.3
—
5
6
(3016502) Oxygen saturation in Arterial blood
168
527
4.22
48.04
13.2
8.6
%
94.1
95.4
1.28
163
507
(3021589) Normoblasts [#/volume] in Blood
368
1953
3.96
47.62
34.3
9.6
e9/l
0.0
0.0
0.54
326
1608
(3036481) Cortisol [Moles/volume] in Serum or Plasma
147
422
4.45
47.27
2.9
2.0
nmol/l
354.7
379.1
0.41
141
387
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
64
85
8.44
46.43
2.4
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
44
35
13.63
45.73
1.8
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
327
1636
3.65
45.70
7.8
3.9
e6/l
23.7
100.7
2.77
284
1181
(3026493) Urate [Moles/volume] in Serum or Plasma
271
1207
3.57
45.53
9.0
2.7
umol/l
4505.6
7321.2
0.47
257
1030
(40767503) Oxygen content in Capillary blood by calculation
66
93
7.97
45.53
2.2
2.5
%
14.7
15.6
0.55
30
49
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
38
24
16.99
44.74
4.4
2.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
38
24
16.99
44.74
4.4
2.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
38
24
16.99
44.74
4.4
2.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
38
24
16.99
44.74
4.4
2.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
231
939
3.61
44.65
16.4
4.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
105
240
5.22
44.58
9.8
4.0
mmol/l
24.0
24.2
0.18
97
219
(3037522) Nuclear Ab [Titer] in Serum
169
566
3.93
43.60
1.7
1.3
titre
290.7
461.8
1.30
41
125
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
230
959
3.49
42.26
2.5
1.7
mg/l
2.2
1.4
0.85
200
742
(3004588) Protein electrophoresis panel - Serum or Plasma
123
334
4.50
42.16
6.2
2.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
113
290
4.69
41.57
1.8
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
34
20
18.11
41.38
4.8
2.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
34
20
18.11
41.38
4.8
2.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
77
144
6.09
40.57
2.0
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
433
2716
4.39
40.46
14.6
5.0
mmol/l
6.8
6.8
0.05
425
2555
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
34
21
17.24
40.40
4.8
2.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
210
859
3.41
39.27
3.1
1.4
g/l
2.3
2.6
0.54
164
508
(3015377) Calcium [Moles/volume] in Serum or Plasma
302
1539
3.27
38.92
10.6
3.6
mmol/l
2.3
2.4
3.54
287
1336
(40768795) Lymph node Pathology biopsy report
45
50
9.75
37.38
1.5
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
247
1145
3.19
37.00
10.7
4.0
%
89.2
89.4
0.04
240
1126
(3012501) Base excess in Blood by calculation
60
97
6.85
36.39
9.5
3.4
mmol/l
2.7
2.5
0.20
53
67
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
39
37
11.31
36.17
1.4
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
42
9
50.58
35.26
1.8
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
62
108
6.38
34.96
2.6
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
60
103
6.45
34.31
1.5
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
40
43
9.99
33.99
1.2
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
71
145
5.51
33.88
1.5
1.5
iu/ml
0.7
0.1
0.47
16
31
(3007853) Bacteria identified in Skin by Aerobe culture
149
541
3.45
33.00
2.3
1.7
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
48
70
7.45
31.91
5.8
6.6
mg/l
11.6
11.2
0.22
43
65
(3031040) Bacteria [#/volume] in Urine by Automated count
436
2948
3.83
31.84
7.9
4.5
e6/l
64.8
2551.9
—
5
48
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
34
32
11.29
31.63
1.1
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
67
141
5.30
30.85
4.4
3.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
272
1446
2.83
30.11
5.9
2.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
69
154
5.01
29.67
9.0
3.5
mg/l
56.1
98.2
0.48
52
121
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
229
1129
2.82
29.07
2.9
2.2
mg/l
3.3
3.1
0.50
212
958
(3026008) Bacteria identified in Urine by Culture
262
1387
2.77
28.93
3.9
3.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
68
154
4.92
28.71
9.1
3.5
mg/l
58.1
35.0
1.18
52
123
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
268
1442
2.75
28.56
4.6
3.0
ng/l
2307.3
1254.8
2.02
250
1231
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
26
20
13.63
27.31
4.8
5.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
38
52
7.80
26.63
1.5
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
83
233
4.04
26.57
1.7
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
24
17
14.75
26.37
1.3
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
89
265
3.84
26.21
20.3
11.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
434
3075
3.37
26.15
9.3
4.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
264
1463
2.62
25.75
3.5
2.5
u/l
60.8
56.6
0.49
250
1350
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
126
477
3.16
25.43
6.5
3.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
185
872
2.73
24.90
5.6
3.9
ng/l
195.4
268.1
0.32
169
723
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
135
538
3.03
24.88
7.7
2.9
umol/l
6.7
9.0
1.00
123
480
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
260
1448
2.58
24.85
8.2
3.4
u/l
37.3
32.5
0.53
255
1378
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
122
461
3.14
24.64
2.5
2.3
g/l
0.2
0.2
1.49
109
425
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
334
2104
2.61
24.46
9.6
4.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
110
394
3.27
24.28
3.7
2.8
ng/l
186.0
200.5
0.15
101
364
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
177
827
2.72
24.12
5.0
3.0
e6/l
1.0
1.1
0.14
118
487
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
19
10
19.68
24.03
1.1
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
49
97
5.47
24.03
1.3
1.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
26
25
10.89
23.74
11.1
6.6
u/ml
49.2
71.6
—
9
5
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
67
174
4.27
23.73
6.9
2.5
g/l
9.2
10.3
0.56
58
149
(40760888) Immunoglobulin light chains.free panel - Serum
53
115
5.01
23.43
9.3
3.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
19
11
17.88
23.01
4.4
5.6
—
—
—
0
0
(3024471) HLA-A [Type]
19
11
17.88
23.01
1.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
22
17
13.46
22.97
1.2
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
103
366
3.26
22.95
7.2
4.2
ng/l
113.4
82.7
2.42
97
325
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
36
55
6.95
22.85
4.3
2.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
29
9
34.00
22.64
1.2
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
166
773
2.68
22.56
5.4
3.2
e6/l
1.5
2.0
0.64
109
439
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
89
296
3.42
22.02
5.9
3.8
mmol/l
1.5
1.9
0.55
72
223
(3013707) Erythrocyte sedimentation rate by Westergren method
442
3287
3.18
21.99
11.3
4.1
mm/h
22.3
12.7
17.48
434
3001
(3035350) Ketones [Presence] in Urine by Test strip
336
2186
2.49
21.96
6.2
3.7
estimate
0.0
0.0
0.00
100
405
(3021601) Nitrite [Presence] in Urine by Test strip
336
2188
2.49
21.89
8.3
5.0
estimate
0.0
0.0
0.00
102
404
(3009343) pH of Capillary blood
92
314
3.34
21.84
5.8
3.7
ph
7.4
7.4
2.62
17
37
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
111
424
3.05
21.81
4.0
2.4
u/l
38.1
33.5
0.46
100
361
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
68
190
3.96
21.77
6.9
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
68
190
3.96
21.77
6.9
2.5
g/l
7.8
7.4
0.75
53
142
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
68
190
3.96
21.77
6.9
2.5
g/l
3.5
3.7
0.30
52
135
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
93
321
3.31
21.67
5.8
3.6
kpa
4.9
5.1
1.23
87
295
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
178
873
2.57
21.62
5.5
3.2
mmol/l
2.5
2.5
0.42
164
765
(3001122) Ferritin [Mass/volume] in Serum or Plasma
288
1759
2.41
21.54
5.1
2.6
ug/l
379.7
149.5
2.40
277
1604
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
24
24
10.43
21.30
1.4
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
24
24
10.43
21.30
1.4
1.8
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
18
11
16.91
21.20
1.9
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
337
2216
2.45
21.20
6.3
3.7
estimate
0.0
0.0
0.00
98
383
(3005322) IgE [Units/volume] in Serum or Plasma
77
239
3.60
21.16
2.3
1.2
u/ml
197.4
298.2
0.40
67
218
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
64
175
4.03
21.10
2.1
2.1
u/l
44.9
38.7
0.92
59
158
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
209
1116
2.45
21.03
5.0
2.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
47
101
5.01
20.98
1.1
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
86
290
3.35
20.77
2.4
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
38
69
5.86
20.38
1.1
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
19
14
14.04
20.32
2.0
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
35
59
6.28
20.22
14.9
3.8
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
31
46
7.10
20.17
11.0
3.3
%
60.0
57.6
0.17
23
34
(3024932) HLA-DR beta [Type]
17
11
15.94
19.43
1.2
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
51
125
4.41
19.39
4.6
2.5
mmol/l
24.7
24.7
0.01
46
107
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
176
3.86
19.36
7.5
2.6
g/l
3.4
3.2
1.13
52
137
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
50
123
4.39
18.92
1.6
1.3
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
26
34
7.99
18.84
1.5
1.3
titre
104.0
98.8
—
5
8
(3020891) Body temperature
67
205
3.60
18.75
6.0
4.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
90
332
3.06
18.62
15.0
8.5
mmol/l
24.5
24.6
0.06
85
309
(3019832) Treponema pallidum Ab [Presence] in Serum
70
222
3.48
18.54
1.7
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
44
101
4.66
18.14
1.9
1.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
75
252
3.31
18.13
7.7
2.6
%
1.3
1.2
0.32
75
252
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
281
1795
2.22
17.69
3.5
2.3
nmol/l
77.9
77.4
0.11
271
1587
(3006184) Hemoglobin [Mass/volume] in Capillary blood
45
108
4.46
17.55
2.1
2.1
g/l
117.1
128.5
1.96
32
76
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
23
8
29.97
17.55
1.4
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
94
369
2.88
17.35
6.8
3.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50
132
4.08
17.23
6.2
2.7
g/l
0.0
0.0
0.00
50
122
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50
134
4.02
16.88
6.2
2.7
g/l
0.0
0.0
0.00
50
123
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
19
19
10.34
16.79
2.2
2.3
ug/l
62.5
74.0
0.18
19
19
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
25
36
7.24
16.67
1.6
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
199
1135
2.21
16.30
2.0
1.5
nmol/l
18.9
20.6
0.81
181
951
(3016650) Hepatitis A virus Ab [Presence] in Serum
36
77
4.95
16.12
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
27
44
6.41
16.08
1.3
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
272
1765
2.12
15.87
2.6
2.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
185
1035
2.22
15.81
5.4
3.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
27
45
6.27
15.73
1.7
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
27
45
6.27
15.73
1.7
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
27
46
6.13
15.40
1.1
1.0
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
50
143
3.76
15.40
6.2
2.7
g/l
0.1
0.0
0.11
50
132
(3019309) Folate [Moles/volume] in Red Blood Cells
161
870
2.23
14.84
1.8
1.7
nmol/l
1201.9
1194.6
0.03
135
661
(21494890) Protein electrophoresis panel - 24 hour Urine
27
48
5.88
14.75
4.6
2.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
34
75
4.78
14.68
1.3
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
28
52
5.63
14.63
1.2
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
24
39
6.40
14.32
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
46
134
3.67
13.78
1.4
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
59
5.14
13.73
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
46
136
3.61
13.48
1.4
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
332
2406
2.03
13.43
3.7
2.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
33
77
4.51
13.31
1.4
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
35
86
4.29
13.23
4.4
2.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
15
15
10.26
13.18
2.5
2.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
269
1821
1.98
13.12
5.7
3.7
ng/l
29.3
46.4
1.63
239
1337
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
18
8
23.23
12.97
1.1
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
16
18
9.14
12.95
4.0
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
33
80
4.33
12.69
1.9
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
44
133
3.52
12.47
1.4
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
17
22
7.95
12.35
2.1
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
108
531
2.30
12.25
5.2
4.3
ug/l
20.9
37.0
0.32
90
453
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
37
103
3.79
11.83
1.9
1.2
e6/l
4.4
9.8
0.39
32
84
(40758292) HTLV I+II Ab panel - Serum
12
10
12.26
11.77
1.2
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
80
351
2.51
11.66
3.7
2.7
ml/min/173m2
57.8
63.6
0.46
25
145
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
44
139
3.36
11.65
2.0
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
39
114
3.62
11.62
10.5
2.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
216
1410
1.90
11.25
3.7
2.2
u/l
103.4
263.4
2.25
207
1325
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
16
8
20.57
11.19
1.9
1.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
25
54
4.81
11.05
1.4
1.2
u/ml
1.4
5.8
—
10
18
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
7
22.00
10.73
5.0
8.9
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
27
64
4.39
10.68
3.7
1.7
pg
31.8
33.4
0.95
27
64
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
12
12
10.21
10.47
1.8
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
27
66
4.26
10.28
1.1
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
18
31
5.98
10.13
3.0
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
18
31
5.98
10.13
5.3
3.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
33
95
3.64
10.06
12.0
2.1
%
57.4
61.0
0.41
33
95
(3029937) Albumin [Presence] in Urine by Test strip
186
1194
1.86
9.94
6.8
4.0
estimate
0.0
0.0
0.00
86
392
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
15
9
17.12
9.92
1.8
2.9
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
21
43
5.05
9.86
5.0
2.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
16
8.31
9.77
2.1
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
14
19
7.54
9.74
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
14
19
7.54
9.74
1.0
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
492
4355
3.06
9.64
70.6
15.3
mg/l
26.5
25.4
0.48
483
3491
(3013637) Mi-2 Ab [Presence] in Serum
11
11
10.19
9.57
1.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
11
11
10.19
9.57
1.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
11
11
10.19
9.57
1.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
11
11
10.19
9.57
1.0
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
87
431
2.22
9.56
2.2
2.6
ug/l
7.6
5.8
0.46
79
383
(3026389) Candida sp identified in Specimen by Organism specific culture
23
53
4.49
9.42
1.2
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
394
3206
1.92
9.40
6.8
4.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
46
172
2.84
9.16
5.9
3.3
g/l
0.3
0.2
0.37
40
74
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
28
77
3.78
9.11
6.5
2.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
14
21
6.82
8.93
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
176
1144
1.81
8.84
1.7
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
18
36
5.14
8.67
1.5
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
13
8
16.61
8.59
1.5
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
13
8
16.61
8.59
1.7
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
260
1907
1.72
8.46
2.4
2.0
pmol/l
91.5
94.8
0.52
166
991
(3045788) Cell count panel - Pleural fluid
20
45
4.58
8.43
1.6
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
23
58
4.10
8.42
1.4
1.2
u/ml
4.6
8.7
—
9
25
(3022313) Gas panel - Capillary blood
56
242
2.47
8.38
7.0
3.7
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
21
50
4.33
8.27
1.8
1.2
e6/l
13486.6
30866.5
0.85
14
27
(4015189)
11
14
8.00
8.01
4.1
2.8
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
15
28
5.49
7.77
2.7
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
40
152
2.77
7.74
17.8
9.9
mmol/l
1.4
1.2
0.84
35
134
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
19
44
4.44
7.74
1.3
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
18
40
4.62
7.70
1.1
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
48
201
2.53
7.68
1.4
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
26
77
3.50
7.62
10.2
3.0
u/ml
37.5
32.3
0.16
26
77
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
34
122
2.91
7.31
1.4
1.3
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
12
19
6.44
7.27
4.3
2.1
%
99.3
109.5
0.31
12
19
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
15
30
5.12
7.22
1.2
1.2
u/l
5.5
6.9
—
10
24
(3051611) Lipemic interference index of Serum or Plasma
19
47
4.16
7.14
5.5
3.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
43
178
2.54
7.05
7.0
1.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
230
1690
1.64
7.03
6.7
3.9
—
—
—
0
0
(3000492) Spirometry study
77
411
2.02
6.91
2.6
1.5
—
—
—
0
0
(4268621)
17
40
4.36
6.80
2.6
2.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
10
6
16.96
6.76
1.4
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
14
28
5.11
6.74
2.8
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
15
32
4.80
6.73
1.9
1.2
u/ml
7.9
0.1
—
7
19
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
10
14
7.26
6.72
1.3
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
44
189
2.45
6.68
1.6
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
29
101
2.98
6.58
1.8
1.5
u/l
11.0
7.5
0.50
21
75
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
112
691
1.79
6.45
1.2
1.3
u/ml
45.5
14.9
0.97
24
265
(40761535) Cells panel - Urine sediment
73
392
2.00
6.43
6.1
3.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
25
81
3.19
6.40
1.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
170
1182
1.65
6.32
6.1
3.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
9
5
18.28
6.28
1.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
35
140
2.61
6.16
1.7
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
17
44
3.96
6.03
1.2
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
114
725
1.73
5.88
1.3
1.3
iu/ml
65.8
38.0
0.80
42
219
(3035880) pH of Pleural fluid
14
32
4.47
5.80
1.4
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
38
165
2.40
5.66
3.6
1.7
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
10
17
5.98
5.64
8.8
3.2
u/l
243.5
220.4
—
10
17
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
27
99
2.82
5.61
1.1
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
25
89
2.90
5.48
1.8
1.6
iu/l
43.2
23.5
1.14
19
74
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
29
112
2.68
5.48
2.3
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
12
26
4.70
5.28
1.6
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
43
205
2.20
5.18
4.3
3.7
u/ml
683.8
6816.3
0.67
38
175
(3003327) Ova and parasites identified in Stool by Light microscopy
32
134
2.48
5.16
1.8
1.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
6
13.51
5.09
1.1
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
17
50
3.48
5.06
1.8
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
9
10.15
5.04
6.4
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
333
2797
1.52
4.98
5.7
3.3
u/l
89.5
54.1
3.88
315
2585
(3011648) Oxygen content in Venous blood
15
41
3.74
4.96
21.5
2.0
%
8.2
10.7
1.68
15
41
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
98
625
1.70
4.95
1.5
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
21
72
3.00
4.93
1.4
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
91
572
1.71
4.85
1.5
1.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
15
42
3.65
4.80
1.9
1.3
%
33.8
30.1
—
10
30
(3009542) Hematocrit [Volume Fraction] of Blood
435
3901
1.67
4.70
62.4
16.6
%
36.2
39.9
11.62
286
2644
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
19
64
3.04
4.60
2.6
1.5
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
5
14.16
4.58
1.4
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
5
14.16
4.58
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
34
3.90
4.56
1.4
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
34
3.90
4.56
1.4
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
34
3.90
4.56
1.4
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
8
8
10.13
4.53
2.3
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
96
626
1.65
4.45
1.4
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
35
3.78
4.39
1.4
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
35
3.78
4.39
1.4
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
35
3.78
4.39
1.4
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
11
26
4.30
4.37
1.5
1.9
—
—
—
0
0
(3034426) Prothrombin time (PT)
9
12
7.61
4.37
1.0
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
62
2.97
4.21
2.7
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
12
32
3.81
4.10
5.3
1.8
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
10
23
4.41
4.10
1.4
1.4
%
48.1
59.8
—
10
16
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
53
3.08
3.99
1.1
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
64
2.88
3.99
2.7
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
45
242
1.94
3.98
2.0
2.4
—
—
—
0
0
(4306422)
15
48
3.19
3.96
1.3
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
14
43
3.32
3.93
1.4
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
489
4582
1.98
3.92
66.9
18.1
mmol/l
138.5
139.7
17.09
489
4463
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
24
4.23
3.90
3.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
24
4.23
3.90
3.0
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
28
127
2.27
3.84
1.4
1.2
titre
84.0
44.3
—
5
7
(3000570) Elastase.pancreatic [Mass/mass] in Stool
29
134
2.23
3.81
1.2
1.4
ug/g
245.5
294.6
0.54
15
77
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
8
8.85
3.78
1.1
1.1
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
6
5
12.12
3.77
7.3
1.4
g/mol
10.2
47.6
—
6
5
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
5
12.12
3.77
1.3
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
35
3.49
3.64
1.2
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
18
69
2.67
3.50
4.6
2.8
mmol/l
4.3
4.0
0.75
18
69
(4010399)
57
347
1.72
3.41
1.9
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
13
42
3.15
3.39
1.5
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
80
533
1.59
3.39
1.4
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
14
5.78
3.35
2.8
1.9
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
7
8.65
3.27
2.5
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
16
60
2.72
3.25
5.6
2.1
u/l
8740.7
3174.8
—
7
21
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
28
3.62
3.21
1.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
7
11
6.43
3.19
1.1
1.1
%
280.3
133.3
—
7
11
(3013512) EKG study
176
1391
1.40
3.17
5.1
4.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
20
4.56
3.12
1.2
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
20
4.56
3.12
1.1
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
8
7.57
3.06
10.0
5.0
mmol/l
5.0
6.5
—
6
8
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
8
7.57
3.06
1.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
8
7.57
3.06
1.2
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
12
5.89
3.03
1.4
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
482
4550
1.72
2.99
47.6
14.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
196
0.30
2.99
1.0
1.5
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
17
69
2.51
2.99
4.8
2.8
mmol/l
106.8
105.0
0.92
17
69
(3033705) Calcium.ionized [Moles/volume] in Venous blood
17
69
2.51
2.99
4.8
2.8
—
—
—
0
0
(40768441) Liver Pathology biopsy report
11
35
3.19
2.94
1.8
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
17
4.76
2.93
1.5
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
416
4448
0.69
2.90
5.5
5.3
mmol/l
2.6
2.7
1.28
376
4048
(3025468) Yersinia sp identified in Specimen by Organism specific culture
16
64
2.55
2.90
2.8
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
64
2.55
2.90
2.8
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
7
13
5.44
2.87
1.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
9
6.73
2.87
1.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
65
2.51
2.81
2.8
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
10
31
3.27
2.78
1.4
3.9
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
9
23
3.96
2.78
4.9
6.3
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
5
6
8.40
2.75
2.8
3.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
14
5.05
2.73
1.0
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
14
54
2.64
2.72
1.9
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
112
1457
0.71
2.71
3.6
3.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
20
92
2.22
2.70
3.8
3.9
u/ml
561.3
473.5
0.06
20
86
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
43
2.83
2.66
1.0
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
7
15
4.71
2.60
3.6
1.7
umol/l
26.4
28.9
—
7
15
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
38
2.94
2.59
1.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
7
7.20
2.55
3.0
3.6
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
7
7.20
2.55
1.0
1.1
%
102.0
82.0
—
5
7
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
7
7.20
2.55
1.0
1.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
5
7
7.20
2.55
1.2
1.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
14
56
2.54
2.55
2.3
1.4
%
58.9
64.7
—
8
40
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
38
225
1.74
2.55
2.5
3.3
pmol/l
4.0
4.5
2.06
32
189
(3027456) Digoxin [Moles/volume] in Serum or Plasma
19
88
2.20
2.54
2.5
3.1
nmol/l
1.0
0.9
0.20
14
70
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
24
123
2.00
2.49
1.5
1.2
—
1.2
—
0
5
(3000475) Leukocytes [#/volume] in Synovial fluid
23
116
2.03
2.49
2.3
1.5
e6/l
8796.4
16096.9
0.63
18
84
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
33
189
1.80
2.47
4.8
3.5
u/ml
53.3
49.1
0.05
33
182
(3000330) Specific gravity of Urine by Test strip
40
243
1.70
2.46
5.3
3.7
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
43
267
1.66
2.44
3.8
2.9
e6/l
0.2
0.3
0.09
43
261
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
10
34
2.98
2.42
1.2
1.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
19
90
2.15
2.41
1.6
1.2
u/ml
48.9
34.3
—
5
9
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
12
5.04
2.41
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
12
5.04
2.41
1.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
8
6.30
2.37
1.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
22
3.68
2.37
1.4
1.0
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
8
22
3.68
2.37
1.4
1.4
%
6.6
1.3
—
8
16
(4027681)
9
28
3.25
2.31
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
14
59
2.41
2.31
2.4
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
38
592
0.61
2.23
3.9
4.8
%
28.3
31.7
1.33
31
383
(3044927) Protein electrophoresis panel - Urine
13
54
2.44
2.21
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
48
2.54
2.20
1.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
25
3.23
2.10
1.1
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
10
5.04
2.07
11.2
2.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
411
4352
0.74
2.02
5.2
4.7
mmol/l
4.5
4.6
0.82
378
3978
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
9
32
2.84
2.01
1.1
1.4
—
24.0
—
0
5
(3006653) Thiamine [Moles/volume] in Blood
7
21
3.36
1.97
2.7
1.4
nmol/l
146.7
144.9
—
7
21
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
11
4.58
1.94
8.0
8.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
16
3.78
1.94
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
22
3.21
1.88
1.3
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
17
3.56
1.84
1.5
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
357
3281
1.28
1.84
4.3
3.8
pmol/l
14.9
14.9
0.05
333
2930
(3048689) Calprotectin [Mass/mass] in Stool
68
500
1.41
1.83
4.0
2.4
ug/g
216.5
127.7
1.10
57
395
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
12
4.20
1.82
8.0
8.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
23
3.07
1.80
1.1
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
121
980
1.30
1.76
1.6
1.7
pmol/l
473.9
12278910.9
0.79
100
790
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
307
0.54
1.76
1.5
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
410
4324
0.76
1.74
5.0
4.6
mmol/l
1.4
1.4
2.16
375
3934
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
24
2.94
1.72
1.1
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
438
4147
1.34
1.72
53.0
14.2
ml/min/173m2
74.0
78.6
3.46
416
3423
(3017732) Neutrophils [#/volume] in Blood
40
271
1.52
1.64
3.8
3.1
e9/l
4.4
4.0
0.37
34
203
(3001019) Free T4 and TSH panel - Serum or Plasma
5
133
0.37
1.64
2.2
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
176
1507
1.25
1.63
5.6
3.1
mmol/l
6.7
7.6
2.33
160
1254
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
14
3.59
1.62
1.4
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
18
311
0.56
1.62
1.2
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
29
183
1.62
1.61
2.5
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
169
1444
1.25
1.59
5.9
3.2
mg/l
1864.8
294.9
1.50
127
928
(3025130) Human papilloma virus identified in Specimen
7
26
2.71
1.58
3.3
1.9
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
7
26
2.71
1.58
4.0
2.5
mu/l
63.9
14.2
—
7
26
(3003338) MCHC [Mass/volume]
385
3598
1.26
1.58
79.7
20.4
g/l
328.6
332.5
12.43
385
3582
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
12
57
2.13
1.56
1.7
2.8
nmol/l
3.4
6.2
0.47
12
57
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
44
0.00
1.52
0.0
1.0
—
600.1
—
0
25
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
44
0.00
1.52
0.0
1.0
—
276.1
—
0
25
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
44
0.00
1.52
0.0
1.0
—
36.9
—
0
23
(3000034) Microalbumin [Mass/volume] in Urine
0
45
0.00
1.50
0.0
4.0
—
17.7
—
0
34
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
16
3.14
1.44
1.4
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
16
3.14
1.44
1.0
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
29
2.43
1.39
4.0
1.4
g/l
0.9
1.0
—
7
29
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
41
2.22
1.37
1.9
1.9
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
23
2.63
1.37
1.0
1.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
11
54
2.06
1.33
2.5
2.8
mg/l
32.6
31.9
—
5
12
(3043410) Blood group antigens tested for on Red Blood Cells
5
18
2.79
1.28
3.6
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
17
99
1.74
1.28
3.0
2.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
22
139
1.61
1.25
6.2
4.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
50
375
1.37
1.25
2.7
2.2
nmol/l
9.9
13.0
1.72
42
328
(3022217) INR in Platelet poor plasma by Coagulation assay
77
616
1.29
1.24
29.8
22.7
inr
1.3
1.3
—
6
85
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
8
37
2.18
1.22
1.1
1.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
496
4836
1.46
1.19
88.1
22.3
fl
92.9
91.3
9.63
496
4759
(3035941) MCH [Entitic mass]
496
4837
1.46
1.18
87.9
22.3
pg
30.6
30.4
1.23
496
4760
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
131
1509
0.82
1.13
3.7
4.5
%
21.8
21.0
0.25
65
734
(3020682) Albumin/Creatinine [Ratio] in Urine
171
1522
1.18
1.02
6.0
4.0
mg/mmol
14.7
8.1
1.36
129
959
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
9
48
1.89
1.01
1.1
1.2
—
—
—
0
0
(44813793)
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
114
983
1.20
0.97
6.3
4.0
kg/l
1.0
1.0
0.03
15
145
(3035320) C reactive protein [Mass/volume] in Body fluid
6
28
2.16
0.91
1.3
2.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
37
280
1.35
0.91
1.4
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
417
4318
0.83
0.91
5.6
4.9
mmol/l
6.1
6.0
0.17
389
3901
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
399
4146
0.84
0.90
7.4
6.3
mmol/mol
40.2
40.4
0.14
378
3830
(4281824)
8
43
1.87
0.87
1.1
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
30
2.01
0.87
1.7
3.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
10
58
1.74
0.80
1.3
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
95
1084
0.85
0.73
2.1
3.1
ug/l
0.7
0.8
0.41
67
734
(3022621) pH of Urine by Test strip
37
292
1.29
0.71
3.3
2.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
15
101
1.50
0.71
1.2
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
7
41
1.72
0.70
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
58
1.56
0.70
1.1
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
32
249
1.30
0.69
1.1
1.2
iu/ml
32.5
155.0
—
10
96
(3020491) Glucose [Moles/volume] in Blood
5
27
1.86
0.68
1.0
2.3
mmol/l
7.9
7.2
—
5
18
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
27
1.86
0.68
1.4
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
71
1.56
0.62
1.7
1.4
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
30
1.67
0.61
1.2
1.1
—
8.0
—
0
7
(4034850)
9
140
0.64
0.61
22.2
12.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
21
0.00
0.60
0.0
1.1
—
7.0
—
0
21
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
67
579
1.18
0.59
24.9
7.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
35
1.72
0.58
1.7
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
35
1.72
0.58
1.7
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
106
952
1.14
0.57
1.2
1.3
u/ml
0.9
1.4
0.83
22
249
(40768800) Prostate Pathology biopsy report
8
122
0.65
0.55
1.0
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
18
134
1.36
0.53
2.1
2.6
ug/min
169.6
112.5
0.31
13
73
(3049717) Cytology report of Urine Cyto stain
27
214
1.28
0.53
2.1
2.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
41
484
0.83
0.49
1.5
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
211
0.75
0.48
1.0
1.0
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
7
46
1.53
0.48
1.1
1.2
nmol/l
1.2
1.8
—
7
41
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
54
468
1.17
0.48
2.2
1.8
%
1.9
1.5
1.06
43
405
(3008898) HLA-B27 [Presence]
18
138
1.32
0.46
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
87
1.39
0.42
1.1
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
32
1.57
0.42
1.6
1.5
u/l
22.8
27.9
—
5
25
(3020191) Ethanol [Moles/volume] in Serum or Plasma
5
32
1.57
0.42
1.2
1.5
promille
1.1
1.4
—
5
25
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
57
1.41
0.42
1.1
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.1
—
0.8
—
0
8
(44806420)
0
17
0.00
0.40
0.0
2.6
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
5
35
1.43
0.39
1.0
1.2
—
2.7
—
0
5
(4094501)
9
121
0.74
0.35
1.1
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
54
1.30
0.30
11.9
1.5
—
—
—
0
0
(3019225) pH of Specimen
51
459
1.12
0.30
15.0
4.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
405
3977
1.08
0.29
5.4
4.6
mu/l
2.1
2.0
0.92
374
3583
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
9
117
0.77
0.27
1.2
1.1
—
10.7
—
0
10
(36660697) Celiac disease serology panel - Serum
37
329
1.13
0.26
1.2
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
25
288
0.86
0.26
1.5
2.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
411
4170
0.93
0.24
5.0
4.2
mmol/l
1.4
1.3
2.67
376
3772
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
84
0.71
0.24
1.3
1.4
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
38
1.32
0.23
1.0
1.2
—
94.4
—
0
5
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
11
135
0.81
0.22
1.9
1.7
nmol/l
45.4
40.5
0.18
11
128
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
18.9
—
0
11
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
12
0.00
0.21
0.0
1.4
—
7.5
—
0
6
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
22
195
1.13
0.17
1.0
1.1
—
28.5
—
0
6
(3013139) Helicobacter pylori Ag [Presence] in Stool
31
283
1.10
0.16
1.2
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
102
1.18
0.15
7.4
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
41
439
0.93
0.14
1.6
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
24
264
0.90
0.14
1.4
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
103
1.17
0.14
7.4
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
103
1.17
0.14
7.4
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
12
103
1.17
0.14
1.2
1.6
—
6.0
—
0
28
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
13
113
1.15
0.13
1.4
2.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
104
1.16
0.12
7.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
155
1.10
0.09
1.9
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
57
1.05
0.08
1.2
1.3
nmol/l
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
11
98
1.13
0.07
8.0
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
72
0.83
0.07
14.2
1.7
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
8
93
0.86
0.06
2.4
1.8
pmol/l
172.9
226.3
—
8
86
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
190
1875
1.02
0.06
4.5
5.1
ug/l
3.4
2.6
0.40
170
1669
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
127
1253
1.02
0.04
1.7
1.7
mmol/l
1.6
1.3
2.70
114
1040
(1002224) Polysomnography panel
15
159
0.94
0.03
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
96
1.04
0.00
1.2
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
10
96
1.04
0.00
1.5
2.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
128
1.02
0.00
1.5
1.7
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
20.1
—
0
9
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
94.0
—
0
6
(3014891) Appearance of Pleural fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.3
—
1.8
—
0
9
(3030313) Adrenal Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
1.4
—
0.4
—
0
5
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
30.0
—
0
5
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
22.8
—
0
5
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
85
0.94
0.00
10.5
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_PNEUMOCYSTOSIS and mortality.

Females

Parameter HR [95% CI] p-value
AB1_PNEUMOCYSTOSIS 10.609 [7.15, 15.75] < 0.001
Birth year 1.003 [0.99, 1.01] 0.449

During the follow-up period (1.1.1998 — 31.12.2019), 296 out of 647 females with AB1_PNEUMOCYSTOSIS died.

Males

Parameter HR [95% CI] p-value
AB1_PNEUMOCYSTOSIS 5.697 [4.03, 8.05] < 0.001
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 404 out of 853 males with AB1_PNEUMOCYSTOSIS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_PNEUMOCYSTOSIS.

N-year risk Females Males
1 1.668% 1.058%
5 7.866% 6.012%
10 18.753% 14.416%
15 32.72% 25.087%
20 51.67% 40.573%

Relationships between endpoints

↥

Index endpoint: AB1_PNEUMOCYSTOSIS – Pneumocystosis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data